| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Celiac Disease | 22 | 2024 | 219 | 4.410 |
Why?
|
| Intestine, Small | 23 | 2025 | 310 | 3.700 |
Why?
|
| Capsule Endoscopy | 14 | 2023 | 33 | 2.980 |
Why?
|
| Endoscopy, Gastrointestinal | 17 | 2021 | 161 | 2.870 |
Why?
|
| Gastrointestinal Hemorrhage | 12 | 2023 | 246 | 1.900 |
Why?
|
| Diet, Gluten-Free | 8 | 2024 | 60 | 1.860 |
Why?
|
| Intestinal Diseases | 5 | 2025 | 85 | 1.630 |
Why?
|
| Double-Balloon Enteroscopy | 5 | 2021 | 11 | 1.520 |
Why?
|
| Parenteral Nutrition | 6 | 2024 | 64 | 1.390 |
Why?
|
| Nutrition Therapy | 3 | 2020 | 10 | 1.330 |
Why?
|
| Glutens | 8 | 2024 | 85 | 1.310 |
Why?
|
| Gastroenterologists | 3 | 2022 | 31 | 0.900 |
Why?
|
| Intestinal Mucosa | 11 | 2020 | 825 | 0.890 |
Why?
|
| Intestinal Neoplasms | 2 | 2020 | 70 | 0.880 |
Why?
|
| Short Bowel Syndrome | 4 | 2024 | 38 | 0.870 |
Why?
|
| Gastroenterology | 5 | 2022 | 157 | 0.850 |
Why?
|
| Gastric Mucosa | 3 | 2013 | 70 | 0.780 |
Why?
|
| Doxycycline | 2 | 2013 | 37 | 0.780 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2013 | 62 | 0.770 |
Why?
|
| Osteoporosis | 2 | 2019 | 131 | 0.750 |
Why?
|
| Nutritional Sciences | 2 | 2018 | 13 | 0.670 |
Why?
|
| Nutrition Assessment | 1 | 2020 | 21 | 0.660 |
Why?
|
| Carcinoid Tumor | 1 | 2020 | 46 | 0.640 |
Why?
|
| Bone Resorption | 1 | 2019 | 45 | 0.610 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2019 | 38 | 0.600 |
Why?
|
| Crohn Disease | 4 | 2020 | 806 | 0.590 |
Why?
|
| Humans | 69 | 2025 | 96112 | 0.550 |
Why?
|
| Adenoma | 1 | 2020 | 260 | 0.550 |
Why?
|
| Osteogenesis | 1 | 2019 | 277 | 0.530 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 847 | 0.530 |
Why?
|
| Betacoronavirus | 1 | 2020 | 284 | 0.520 |
Why?
|
| Enteral Nutrition | 3 | 2016 | 105 | 0.520 |
Why?
|
| Intensive Care Units | 1 | 2020 | 460 | 0.500 |
Why?
|
| Esophagitis | 2 | 2013 | 43 | 0.500 |
Why?
|
| Education, Medical, Graduate | 2 | 2018 | 436 | 0.500 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 145 | 0.490 |
Why?
|
| Metabolic Syndrome | 1 | 2017 | 127 | 0.490 |
Why?
|
| Gastrointestinal Agents | 2 | 2020 | 183 | 0.480 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 346 | 0.460 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 334 | 0.460 |
Why?
|
| Adenocarcinoma | 3 | 2020 | 1215 | 0.450 |
Why?
|
| Peptides | 3 | 2020 | 672 | 0.440 |
Why?
|
| Embolization, Therapeutic | 1 | 2016 | 279 | 0.410 |
Why?
|
| Transglutaminases | 3 | 2020 | 41 | 0.340 |
Why?
|
| Gastrointestinal Diseases | 4 | 2014 | 154 | 0.340 |
Why?
|
| Jejunum | 1 | 2010 | 80 | 0.330 |
Why?
|
| Risk Factors | 9 | 2020 | 5961 | 0.330 |
Why?
|
| Retrospective Studies | 12 | 2024 | 10287 | 0.310 |
Why?
|
| Female | 29 | 2025 | 50045 | 0.310 |
Why?
|
| Jejunal Neoplasms | 1 | 2009 | 9 | 0.310 |
Why?
|
| Ileal Neoplasms | 1 | 2009 | 9 | 0.310 |
Why?
|
| Duodenal Neoplasms | 1 | 2009 | 21 | 0.310 |
Why?
|
| Intestinal Perforation | 1 | 2009 | 39 | 0.300 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 72 | 0.300 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 7230 | 0.300 |
Why?
|
| Pancreatitis | 1 | 2009 | 94 | 0.290 |
Why?
|
| Endoscopes, Gastrointestinal | 2 | 2007 | 8 | 0.290 |
Why?
|
| Bone Density | 2 | 2019 | 239 | 0.280 |
Why?
|
| Monitoring, Physiologic | 1 | 2009 | 273 | 0.270 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 475 | 0.270 |
Why?
|
| Gastrostomy | 3 | 2016 | 69 | 0.260 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2015 | 320 | 0.260 |
Why?
|
| Middle Aged | 21 | 2025 | 28371 | 0.260 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 159 | 0.260 |
Why?
|
| Adult | 21 | 2025 | 28725 | 0.250 |
Why?
|
| Aged | 17 | 2025 | 20972 | 0.240 |
Why?
|
| Catheterization | 4 | 2009 | 238 | 0.240 |
Why?
|
| Male | 25 | 2025 | 45871 | 0.230 |
Why?
|
| Obesity | 3 | 2017 | 1034 | 0.230 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2025 | 6 | 0.230 |
Why?
|
| Interleukin-15 | 3 | 2015 | 76 | 0.220 |
Why?
|
| Rituximab | 1 | 2025 | 133 | 0.220 |
Why?
|
| Fish Oils | 1 | 2024 | 15 | 0.220 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2024 | 15 | 0.220 |
Why?
|
| Inflammation | 3 | 2019 | 1068 | 0.190 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2023 | 22 | 0.190 |
Why?
|
| Diarrhea | 2 | 2014 | 181 | 0.190 |
Why?
|
| Liver Diseases | 1 | 2024 | 249 | 0.190 |
Why?
|
| Quality of Life | 2 | 2024 | 1816 | 0.180 |
Why?
|
| Young Adult | 6 | 2020 | 7025 | 0.180 |
Why?
|
| HLA-DQ Antigens | 2 | 2019 | 52 | 0.170 |
Why?
|
| Patient Education as Topic | 1 | 2024 | 378 | 0.170 |
Why?
|
| Calcium | 3 | 2019 | 1205 | 0.170 |
Why?
|
| Sweden | 1 | 2020 | 46 | 0.160 |
Why?
|
| Registries | 2 | 2020 | 986 | 0.160 |
Why?
|
| Deficiency Diseases | 1 | 1999 | 12 | 0.160 |
Why?
|
| Antigens | 2 | 2019 | 231 | 0.150 |
Why?
|
| Biopsy | 5 | 2025 | 1220 | 0.150 |
Why?
|
| Th1 Cells | 2 | 2017 | 171 | 0.150 |
Why?
|
| Zinc | 1 | 1999 | 101 | 0.150 |
Why?
|
| Central Venous Catheters | 1 | 2019 | 22 | 0.150 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2019 | 71 | 0.150 |
Why?
|
| Atrophy | 1 | 2018 | 132 | 0.140 |
Why?
|
| Osteoporotic Fractures | 1 | 2019 | 53 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 111 | 0.140 |
Why?
|
| Gastrointestinal Hormones | 1 | 1997 | 8 | 0.140 |
Why?
|
| Reoviridae Infections | 1 | 2017 | 7 | 0.130 |
Why?
|
| Avena | 1 | 2017 | 19 | 0.130 |
Why?
|
| Fatal Outcome | 2 | 2016 | 304 | 0.130 |
Why?
|
| Vitamin D | 1 | 2019 | 273 | 0.130 |
Why?
|
| Intestinal Absorption | 3 | 2019 | 126 | 0.130 |
Why?
|
| Autoantibodies | 3 | 2020 | 281 | 0.120 |
Why?
|
| Vital Capacity | 1 | 2016 | 73 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 2 | 2022 | 1096 | 0.120 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2016 | 27 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2020 | 1010 | 0.120 |
Why?
|
| Curriculum | 2 | 2018 | 615 | 0.120 |
Why?
|
| Equipment Design | 3 | 2019 | 427 | 0.120 |
Why?
|
| Leukotrienes | 1 | 2015 | 20 | 0.120 |
Why?
|
| United States | 6 | 2015 | 7768 | 0.120 |
Why?
|
| Malnutrition | 1 | 2016 | 36 | 0.120 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2015 | 35 | 0.120 |
Why?
|
| Genetic Testing | 1 | 2019 | 565 | 0.120 |
Why?
|
| Attitude | 1 | 2016 | 137 | 0.120 |
Why?
|
| Overweight | 1 | 2016 | 121 | 0.120 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 153 | 0.120 |
Why?
|
| Treatment Outcome | 6 | 2017 | 9176 | 0.110 |
Why?
|
| Adolescent | 6 | 2016 | 9895 | 0.110 |
Why?
|
| Cysteine | 1 | 2015 | 146 | 0.110 |
Why?
|
| Pandemics | 1 | 2020 | 880 | 0.110 |
Why?
|
| Immunoglobulin A | 2 | 2020 | 91 | 0.110 |
Why?
|
| Cell Communication | 1 | 2015 | 221 | 0.110 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 180 | 0.100 |
Why?
|
| Abdominal Pain | 2 | 2013 | 145 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 1807 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2014 | 2781 | 0.100 |
Why?
|
| Mentors | 1 | 2014 | 101 | 0.100 |
Why?
|
| Capsule Endoscopes | 1 | 2013 | 5 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2015 | 252 | 0.100 |
Why?
|
| Colitis, Ulcerative | 1 | 2020 | 801 | 0.100 |
Why?
|
| Child | 4 | 2023 | 7625 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1994 | 509 | 0.100 |
Why?
|
| Capillaries | 1 | 2013 | 86 | 0.100 |
Why?
|
| Endoscopy, Digestive System | 1 | 2013 | 72 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2020 | 2480 | 0.090 |
Why?
|
| Necrosis | 1 | 2013 | 210 | 0.090 |
Why?
|
| Faculty, Medical | 1 | 2014 | 207 | 0.090 |
Why?
|
| Radiography, Abdominal | 1 | 2012 | 68 | 0.090 |
Why?
|
| Withholding Treatment | 1 | 2013 | 121 | 0.090 |
Why?
|
| Carrier Proteins | 3 | 1996 | 683 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 3652 | 0.090 |
Why?
|
| Cystic Fibrosis | 1 | 1993 | 121 | 0.090 |
Why?
|
| Stomach | 2 | 2010 | 115 | 0.090 |
Why?
|
| Time Factors | 1 | 2020 | 5585 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2016 | 2591 | 0.090 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 99 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2015 | 705 | 0.090 |
Why?
|
| Angiography | 1 | 2011 | 209 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 2 | 2022 | 155 | 0.090 |
Why?
|
| Jejunostomy | 1 | 2010 | 13 | 0.080 |
Why?
|
| Sodium | 2 | 2000 | 340 | 0.080 |
Why?
|
| Remission Induction | 1 | 2013 | 769 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1990 | 39 | 0.080 |
Why?
|
| Ileostomy | 1 | 2010 | 29 | 0.080 |
Why?
|
| Consensus | 2 | 2022 | 370 | 0.080 |
Why?
|
| Tretinoin | 1 | 2011 | 131 | 0.080 |
Why?
|
| Adjuvants, Immunologic | 1 | 2011 | 174 | 0.080 |
Why?
|
| Ultrasonography | 1 | 2012 | 744 | 0.080 |
Why?
|
| Parenteral Nutrition, Home | 1 | 2009 | 1 | 0.080 |
Why?
|
| Intestinal Polyposis | 1 | 2009 | 5 | 0.080 |
Why?
|
| Malabsorption Syndromes | 1 | 2009 | 22 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 777 | 0.080 |
Why?
|
| Gastric Balloon | 1 | 2009 | 1 | 0.080 |
Why?
|
| Intubation, Gastrointestinal | 2 | 2006 | 31 | 0.070 |
Why?
|
| Neoplasms | 1 | 2024 | 3248 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2020 | 1958 | 0.070 |
Why?
|
| Interviews as Topic | 1 | 2009 | 376 | 0.070 |
Why?
|
| GTP-Binding Proteins | 2 | 2020 | 148 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 3927 | 0.060 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2006 | 26 | 0.060 |
Why?
|
| Intestinal Obstruction | 1 | 2007 | 94 | 0.060 |
Why?
|
| Duodenal Obstruction | 1 | 2006 | 4 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 935 | 0.060 |
Why?
|
| Chronic Disease | 3 | 2019 | 983 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 1987 | 284 | 0.060 |
Why?
|
| Ileocecal Valve | 1 | 2005 | 4 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 2 | 2010 | 725 | 0.060 |
Why?
|
| Gastric Bypass | 1 | 2006 | 114 | 0.060 |
Why?
|
| Patient Selection | 1 | 2009 | 709 | 0.060 |
Why?
|
| Biological Transport | 2 | 1999 | 412 | 0.060 |
Why?
|
| Ileum | 2 | 2019 | 169 | 0.050 |
Why?
|
| Chicago | 1 | 2009 | 1506 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2006 | 294 | 0.050 |
Why?
|
| Palliative Care | 1 | 2006 | 273 | 0.050 |
Why?
|
| Interferon-gamma | 2 | 2006 | 467 | 0.050 |
Why?
|
| Stents | 1 | 2006 | 425 | 0.050 |
Why?
|
| Hepatitis B virus | 1 | 2003 | 48 | 0.050 |
Why?
|
| Endoscopy | 1 | 2006 | 374 | 0.050 |
Why?
|
| Virus Activation | 1 | 2003 | 43 | 0.050 |
Why?
|
| Hepatitis B | 1 | 2003 | 82 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2023 | 196 | 0.050 |
Why?
|
| Advisory Committees | 1 | 2022 | 94 | 0.050 |
Why?
|
| Animals | 9 | 2017 | 28919 | 0.040 |
Why?
|
| Immune Tolerance | 2 | 2017 | 385 | 0.040 |
Why?
|
| Hospitals | 1 | 2024 | 329 | 0.040 |
Why?
|
| Chlorides | 3 | 2000 | 108 | 0.040 |
Why?
|
| Diet | 2 | 2017 | 461 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2023 | 197 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2015 | 3581 | 0.040 |
Why?
|
| Antibodies | 1 | 2022 | 356 | 0.040 |
Why?
|
| Ions | 1 | 2000 | 80 | 0.040 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2003 | 199 | 0.040 |
Why?
|
| Thymidine Phosphorylase | 1 | 2000 | 5 | 0.040 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2000 | 4 | 0.040 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2000 | 7 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 1645 | 0.040 |
Why?
|
| Saccharomyces | 1 | 2020 | 22 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1755 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 1996 | 1010 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2000 | 110 | 0.040 |
Why?
|
| Biological Availability | 1 | 1999 | 89 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2006 | 1667 | 0.040 |
Why?
|
| Duodenum | 1 | 2019 | 112 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2000 | 526 | 0.040 |
Why?
|
| Amiloride | 2 | 1990 | 36 | 0.040 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2019 | 18 | 0.040 |
Why?
|
| Butyrophilins | 1 | 2019 | 28 | 0.040 |
Why?
|
| Sodium-Hydrogen Exchangers | 2 | 1990 | 78 | 0.040 |
Why?
|
| Chickens | 2 | 1990 | 213 | 0.040 |
Why?
|
| Fractures, Bone | 1 | 2000 | 155 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 1996 | 1276 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2940 | 0.030 |
Why?
|
| Imidazoles | 2 | 1990 | 144 | 0.030 |
Why?
|
| Enterochromaffin Cells | 1 | 1997 | 2 | 0.030 |
Why?
|
| Natriuretic Peptides | 1 | 1997 | 7 | 0.030 |
Why?
|
| Chloride Channels | 2 | 1996 | 43 | 0.030 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2017 | 7 | 0.030 |
Why?
|
| Reoviridae | 1 | 2017 | 6 | 0.030 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2017 | 19 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 22 | 0.030 |
Why?
|
| Stomach Diseases | 1 | 1997 | 19 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1997 | 297 | 0.030 |
Why?
|
| Visual Analog Scale | 1 | 2016 | 18 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 3110 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2017 | 56 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 3490 | 0.030 |
Why?
|
| Sarcoidosis | 1 | 1997 | 74 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2019 | 304 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1471 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 706 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2017 | 120 | 0.030 |
Why?
|
| Lauric Acids | 1 | 1996 | 1 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 432 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2003 | 882 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2011 | 1157 | 0.030 |
Why?
|
| Receptors, Purinergic P2 | 1 | 1996 | 16 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1349 | 0.030 |
Why?
|
| Receptors, Leukotriene | 1 | 2015 | 10 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2017 | 206 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 125 | 0.030 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2015 | 22 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2016 | 133 | 0.030 |
Why?
|
| Certification | 1 | 2016 | 66 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 3040 | 0.030 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2015 | 33 | 0.030 |
Why?
|
| Italy | 1 | 2015 | 112 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 2040 | 0.030 |
Why?
|
| Ion Channels | 2 | 1996 | 260 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 127 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2015 | 118 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 184 | 0.030 |
Why?
|
| Steatorrhea | 1 | 2014 | 4 | 0.030 |
Why?
|
| Pancreatic Function Tests | 1 | 2014 | 7 | 0.030 |
Why?
|
| Breath Tests | 1 | 2014 | 58 | 0.030 |
Why?
|
| Intestines | 1 | 2017 | 431 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2014 | 43 | 0.030 |
Why?
|
| Peptide Hormones | 1 | 2014 | 30 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2014 | 192 | 0.030 |
Why?
|
| Bile Acids and Salts | 1 | 2014 | 77 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2014 | 327 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 1546 | 0.020 |
Why?
|
| China | 1 | 2014 | 264 | 0.020 |
Why?
|
| Endocytosis | 1 | 1994 | 186 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1176 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 740 | 0.020 |
Why?
|
| Research Design | 2 | 2006 | 631 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2016 | 815 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 514 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 1932 | 0.020 |
Why?
|
| Mice | 3 | 2017 | 12541 | 0.020 |
Why?
|
| Operative Time | 1 | 2013 | 167 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 929 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 653 | 0.020 |
Why?
|
| Feces | 1 | 2014 | 360 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1997 | 2090 | 0.020 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2011 | 9 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2011 | 22 | 0.020 |
Why?
|
| Gliadin | 1 | 2011 | 17 | 0.020 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1990 | 13 | 0.020 |
Why?
|
| Jejunal Diseases | 1 | 2010 | 10 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 172 | 0.020 |
Why?
|
| Interleukin-23 | 1 | 2011 | 60 | 0.020 |
Why?
|
| Surgical Stapling | 1 | 2010 | 17 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 777 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 1990 | 62 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2474 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2011 | 116 | 0.020 |
Why?
|
| Isoquinolines | 1 | 1990 | 73 | 0.020 |
Why?
|
| Diverticulum | 1 | 2010 | 45 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2016 | 854 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 180 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2550 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 771 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 688 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1993 | 2090 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2010 | 182 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 2579 | 0.020 |
Why?
|
| Mutation | 1 | 2000 | 4374 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 2860 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 350 | 0.020 |
Why?
|
| Nigericin | 1 | 1987 | 2 | 0.020 |
Why?
|
| Valinomycin | 1 | 1987 | 8 | 0.020 |
Why?
|
| Calcimycin | 1 | 1987 | 33 | 0.020 |
Why?
|
| Buffers | 1 | 1987 | 26 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 1987 | 20 | 0.020 |
Why?
|
| Alprostadil | 1 | 1987 | 26 | 0.020 |
Why?
|
| Chelating Agents | 1 | 1987 | 68 | 0.020 |
Why?
|
| Glycine | 1 | 1987 | 96 | 0.020 |
Why?
|
| Butyrates | 1 | 1987 | 59 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2011 | 541 | 0.020 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2006 | 18 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2006 | 138 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2016 | 1134 | 0.020 |
Why?
|
| Mesentery | 1 | 2006 | 45 | 0.020 |
Why?
|
| North America | 1 | 2006 | 199 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2006 | 145 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 2006 | 137 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 2006 | 155 | 0.010 |
Why?
|
| Weight Loss | 1 | 2006 | 240 | 0.010 |
Why?
|
| Peritoneal Neoplasms | 1 | 2006 | 187 | 0.010 |
Why?
|
| Lymphoma | 1 | 2006 | 271 | 0.010 |
Why?
|
| Obesity, Morbid | 1 | 2006 | 247 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2010 | 784 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 3974 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 416 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 2344 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 2003 | 147 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2000 | 105 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2000 | 128 | 0.010 |
Why?
|
| Blepharoptosis | 1 | 2000 | 11 | 0.010 |
Why?
|
| Ophthalmoplegia | 1 | 2000 | 12 | 0.010 |
Why?
|
| Cell Line | 2 | 1996 | 2537 | 0.010 |
Why?
|
| Mitochondria, Muscle | 1 | 2000 | 27 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2000 | 94 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2000 | 89 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2000 | 87 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1535 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2000 | 124 | 0.010 |
Why?
|
| Potassium | 1 | 2000 | 271 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2000 | 212 | 0.010 |
Why?
|
| Point Mutation | 1 | 2000 | 247 | 0.010 |
Why?
|
| Syndrome | 1 | 2000 | 453 | 0.010 |
Why?
|
| Age of Onset | 1 | 2000 | 344 | 0.010 |
Why?
|
| Comorbidity | 1 | 2003 | 1011 | 0.010 |
Why?
|
| Introns | 1 | 2000 | 304 | 0.010 |
Why?
|
| Exons | 1 | 2000 | 454 | 0.010 |
Why?
|
| Liver | 1 | 2003 | 1238 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2006 | 4672 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 2061 | 0.010 |
Why?
|
| Glucose | 1 | 2000 | 701 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 483 | 0.010 |
Why?
|
| Proteolipids | 1 | 1996 | 8 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1996 | 8 | 0.010 |
Why?
|
| Anions | 1 | 1996 | 31 | 0.010 |
Why?
|
| Photochemistry | 1 | 1996 | 38 | 0.010 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 1996 | 9 | 0.010 |
Why?
|
| Uridine Triphosphate | 1 | 1996 | 7 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1996 | 103 | 0.010 |
Why?
|
| Uncoupling Protein 1 | 1 | 1996 | 44 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 1996 | 29 | 0.010 |
Why?
|
| Ion Transport | 1 | 1996 | 87 | 0.010 |
Why?
|
| Xenopus | 1 | 1996 | 130 | 0.010 |
Why?
|
| Protons | 1 | 1996 | 104 | 0.010 |
Why?
|
| Adipose Tissue, Brown | 1 | 1996 | 96 | 0.010 |
Why?
|
| Connexin 43 | 1 | 1996 | 94 | 0.010 |
Why?
|
| Cricetinae | 1 | 1996 | 542 | 0.010 |
Why?
|
| Radiography | 1 | 1997 | 826 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 1996 | 129 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1996 | 198 | 0.010 |
Why?
|
| Oocytes | 1 | 1996 | 227 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1996 | 329 | 0.010 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1994 | 16 | 0.010 |
Why?
|
| Transferrin | 1 | 1994 | 21 | 0.010 |
Why?
|
| Receptors, Transferrin | 1 | 1994 | 11 | 0.010 |
Why?
|
| Colforsin | 1 | 1994 | 75 | 0.010 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 1994 | 57 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 2463 | 0.010 |
Why?
|
| Binding Sites | 1 | 1996 | 1167 | 0.010 |
Why?
|
| Iron | 1 | 1994 | 179 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1994 | 445 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 1049 | 0.010 |
Why?
|
| Transfection | 1 | 1994 | 908 | 0.010 |
Why?
|
| Kinetics | 1 | 1994 | 1562 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1994 | 695 | 0.010 |
Why?
|